CENGENT THERAPEUTICS, INC.
Patent Owner
Stats
- 0 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Jun 03, 2008 most recent publication
Details
- 0 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 85 Total Citation Count
- Mar 19, 2003 Earliest Filing
- 8 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
- No Technology to Display
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
- No Recent Patents to Display
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
7381736 Thiazole and thiadiazole inhibitors of tyrosine phosphatasesExpiredSep 02, 05Jun 03, 08[A61K]
2008/0070,867 2-Imidazolone and 2-Imidazolidinone Heterocyclic Inhibitors of Tyrosine PhosphatasesAbandonedJan 17, 06Mar 20, 08[A61K, C07F, A61P]
2006/0135,483 Oxygen/nitrogen heterocycle inhibitors of tyrosine phosphatasesAbandonedJul 08, 05Jun 22, 06[A61K, C07F]
2006/0135,773 Trisubstituted nitrogen modulators of tyrosine phosphatasesAbandonedJun 17, 05Jun 22, 06[C07F, C07D]
2005/0004,766 Use of computationally derived protein structures of genetic polymorphisms in pharmacogenomics for drug design and clinical applicationsAbandonedAug 04, 04Jan 06, 05[G01N, G06F]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.